Transcriptional basis of embryonic macrophage development
胚胎巨噬细胞发育的转录基础
基本信息
- 批准号:10531441
- 负责人:
- 金额:$ 19.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
ABSTRACT
It has been appreciated recently that tissue-resident macrophages (TRMs) contribute to tissue homeostasis.
For example, in the brain, microglia have been proposed to process extracellular proteins and to restrict the
formation of plaque formed from proteins such as -amyloid and Tau proteins. Such tissue-resident macro-
phages were once thought to be derived from monocytes that arise in definitive hematopoiesis in the adult
bone marrow. However, we now understand that TRMs are derived during fetal life and arise from progenitors
in the yolk sac and fetal liver. In some tissues, these embryonically derived macrophage populations persist
throughout adult life and are not efficiently replaced by circulating monocytes arising from adult bone marrow
and definitive hematopoiesis. One impediment to studying the functions of such embryonically derived macro-
phages is the relative paucity of information regarding their development, specifically the transcriptional pro-
grams that guide their development. The lack of such information prevents the design of model systems where
these cells can be prevented from developing, which would allow their in vivo functions to be defined in a defin-
itive way. The current application is aimed at defining the basis for the embryonic development of macrophag-
es. It is based on preliminary data that has: 1) identified the Zeb2 enhancer (at -165kb) used in definitive
hematopoiesis supporting monocyte/macrophage development from the adult bone marrow; 2) showed that
this enhancer is not required for Zeb2 expression in embryonic macrophage development, and 3) identified two
other Zeb2 enhancers that are selectively active in the embryonic yolk sac and fetal liver progenitors.
This application will (Aim 1) test these embryonically active Zeb2 enhancers for their role in supporting embry-
onic macrophage development, and (Aim 2) determine the transcriptional basis for their embryonic activity.
Aim 1 may directly produce models of embryonic macrophage deficiency, which would immediately benefit re-
search in other areas related to immune cell support of tissue homeostasis. Beyond this, the basic information
on the similarities or differences between primitive and adult hematopoiesis could have further uses, such as in
adding to ways in which fetal gene expression can be controlled to compensate for innate or acquired defects
in adult gene expression, such as in -thalassemia.
抽象的
最近人们对组织居民巨噬细胞(TRM)有助于组织稳态。
例如,在大脑中,已经提出了小胶质细胞来处理细胞外蛋白质并限制
由蛋白(例如淀粉样蛋白和tau蛋白)形成的斑块形成。这样的组织居民宏观
曾经认为噬菌体源自成人造血的单核细胞
骨髓。但是,我们现在了解到TRM是在胎儿生活中得出的,并且来自祖细胞
在某些组织中,这些胚胎衍生的巨噬细胞种群持续存在
在整个成人生活中,不被成年骨髓引起的循环单核细胞有效地取代
和确定的造血。研究这种胚胎衍生的宏的功能的一种障碍
噬菌体是相对缺乏有关其发展的信息,特别是转录副本
指导他们发展的克。缺乏此类信息阻止了模型系统的设计
可以防止这些细胞发育,这将使它们的体内函数在定义中定义 -
IDIVE方式。当前的应用旨在定义巨噬菌的胚胎发展的基础。
es。它基于具有:1)确定Zeb2增强子(AT -165KB)的初步数据
由成年骨髓支撑单核细胞/巨噬细胞发育的造血症; 2)显示
在胚胎巨噬细胞发展中Zeb2表达不需要此增强子,3)确定了两个
其他在胚胎蛋黄和胎儿肝祖细胞中有选择性活跃的Zeb2增强剂。
该应用将(AIM 1)测试这些具有胚胎活跃的Zeb2增强子,以在支持胚胎中的作用
ONIC巨噬细胞的发展,(目标2)确定其胚胎活性的转录基础。
AIM 1可能直接产生胚胎巨噬细胞缺乏症的模型,这将立即受益
在与组织稳态支持的其他领域进行搜索。除此之外,基本信息
关于原始造血和成人造血之间的相似性或差异,例如
增加可以控制胎儿基因表达以补偿先天或获得的缺陷的方式
在成年基因表达中,例如在thalassymia中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Kenneth M Murphy其他文献
Recent progress in type 1 classical dendritic cell cross-presentation - cytosolic, vacuolar, or both?
- DOI:10.1016/j.coi.2023.10235010.1016/j.coi.2023.102350
- 发表时间:2023-08-012023-08-01
- 期刊:
- 影响因子:
- 作者:Ray A Ohara;Kenneth M MurphyRay A Ohara;Kenneth M Murphy
- 通讯作者:Kenneth M MurphyKenneth M Murphy
共 1 条
- 1
Kenneth M Murphy的其他基金
Molecular Basis of cDC1 Development
cDC1 开发的分子基础
- 批准号:1045055310450553
- 财政年份:2022
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Molecular Basis of cDC1 Development
cDC1 开发的分子基础
- 批准号:1064973610649736
- 财政年份:2022
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Transcriptional basis of embryonic macrophage development
胚胎巨噬细胞发育的转录基础
- 批准号:1065485810654858
- 财政年份:2022
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Understanding the Mechanisms of DC Licensing in CD8 T Cell Priming
了解 CD8 T 细胞启动中 DC 许可的机制
- 批准号:1021169410211694
- 财政年份:2021
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Understanding the Mechanisms of DC Licensing in CD8 T Cell Priming
了解 CD8 T 细胞启动中 DC 许可的机制
- 批准号:1041199310411993
- 财政年份:2021
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Mechanism of c-MYC repression by IRF8 in myeloid lineages
IRF8 在骨髓谱系中抑制 c-MYC 的机制
- 批准号:1037967510379675
- 财政年份:2021
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Understanding the Mechanisms of DC Licensing in CD8 T Cell Priming
了解 CD8 T 细胞启动中 DC 许可的机制
- 批准号:1063093810630938
- 财政年份:2021
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Mechanism of c-MYC repression by IRF8 in myeloid lineages
IRF8 在骨髓谱系中抑制 c-MYC 的机制
- 批准号:1049338910493389
- 财政年份:2021
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Function of Wdfy4 in cross-presentation and immunity
Wdfy4在交叉呈递和免疫中的功能
- 批准号:1020375210203752
- 财政年份:2019
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Function of Wdfy4 in cross-presentation and immunity
Wdfy4在交叉呈递和免疫中的功能
- 批准号:1043014410430144
- 财政年份:2019
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
相似国自然基金
玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
- 批准号:42307523
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
- 批准号:62372469
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
IRF9调控CD8+T细胞介导微波消融联合TIGIT单抗协同增效抗肿瘤的作用机制
- 批准号:82373219
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
建立可诱导细胞消融系统揭示成纤维细胞在墨西哥钝口螈肢体发育及再生中的作用
- 批准号:32300701
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肿瘤源PPIA介导结直肠癌肝转移射频消融术残瘤化疗抵抗的机制研究
- 批准号:82302332
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Epigenetic reprogramming of cardiac myofibroblasts for cardiac repair
心肌成纤维细胞的表观遗传重编程用于心脏修复
- 批准号:1071364710713647
- 财政年份:2023
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Fibroblast dysregulation promotes dermal eosinophilic/Th2 inflammation
成纤维细胞失调促进真皮嗜酸性/Th2炎症
- 批准号:1072587010725870
- 财政年份:2023
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Species-Specific Epigenetic Basis of Zebrafish Inner Ear Hair Cell Regeneration
斑马鱼内耳毛细胞再生的物种特异性表观遗传基础
- 批准号:1073276110732761
- 财政年份:2022
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Desmosomes in cardiomyocyte homeostasis and disease
桥粒在心肌细胞稳态和疾病中的作用
- 批准号:1060689410606894
- 财政年份:2022
- 资助金额:$ 19.69万$ 19.69万
- 项目类别:
Acceptance of non-self: Decoding intestinal immune tolerance during early life
接受非自我:解码生命早期的肠道免疫耐受
- 批准号:1067772810677728
- 财政年份:2022
- 资助金额:$ 19.69万$ 19.69万
- 项目类别: